Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England-Reference-Cited by-同舟云学术

Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England

Published:2022-08 Issue: Volume:Volume 17 Page:1781-1795
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Requena Gema^ORCID,Banks Victoria^ORCID,Czira Alexandrosz,Wood Robert^ORCID,Tritton Theo,Wild Rosie^ORCID,Compton Chris,Duarte Maria,Ismaila Afisi S^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference34 articles.

1. What is early COPD and why is it important?

2. Pathophysiology of the Small Airways in Chronic Obstructive Pulmonary Disease

3. G. B. D. Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3

4. British Lung Foundation. Chronic obstructive pulmonary disease (COPD) statistics; 2021. Available from: https://statistics.blf.org.uk/copd. Accessed October 2021.

5. Health and Safety Executive. Work-related chronic obstructive pulmonary disease (COPD) statistics in Great Britain; 2020. Available from: https://www.hse.gov.uk/statistics/causdis/copd.pdf. Accessed October 2020.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England;International Journal of Chronic Obstructive Pulmonary Disease;2023-09

2. Real-world comparative effectiveness of three single-inhaler dual bronchodilators for the treatment of COPD;European Respiratory Journal;2023-06-21

3. Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England;International Journal of Chronic Obstructive Pulmonary Disease;2023-03